Virtual reality offers a new way to breathe easier for lung disease patients
NCT ID NCT07628725
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a virtual reality (VR) program that guides slow, controlled breathing and arm exercises can help people with interstitial lung disease (ILD) manage symptoms like breathlessness and fatigue. Participants will either use a VR headset or follow printed instructions at home. The study will measure changes in breathing, fatigue, exercise ability, and quality of life to see if the VR approach is practical and helpful.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Virtual reality-assisted breathing exercises
What this could lead to
If effective, this VR program could offer a new, engaging way to help people with ILD manage breathlessness and improve daily function at home.
What could go wrong
This is a small, early feasibility study with only 32 participants. It is designed to test usability, not yet to prove the treatment works. Some people may find VR uncomfortable or difficult to use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTERSTITIAL LUNG DISEASE (ILD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••